BillionToOne expanding into multi-assay diagnostics

Single base pair precision turns BillionToOne from a prenatal test seller into a reusable detection engine for any blood test where the hard part is finding one tiny mutated fragment among a huge background of normal DNA. That matters because rare disease carrier screening, drug response genotyping, and many infectious disease assays all come down to the same job, measuring a very specific sequence change accurately enough that a doctor can act on one blood draw.1 2 3 4

• In prenatal care, the platform already shows the practical use case. It reads fetal risk for recessive disorders like cystic fibrosis, SMA, and sickle cell disease from maternal blood, without a partner sample or amniocentesis. That proves the system can call clinically important single letter DNA changes in a noisy sample, which is the same core challenge in many non prenatal assays.2 3 4
• In oncology, the same counting approach has already been repurposed into Northstar tests for therapy selection and treatment response monitoring. That is the clearest evidence that the platform is not tied to one workflow or customer. It can move from OB and fertility clinics into cancer care, where doctors order serial blood tests to spot mutation driven treatment changes earlier.1 2 4 5
• The business implication is that each new assay can reuse the same underlying molecular counting stack while selling into different budgets and specialists. BillionToOne estimated 2024 revenue at $153M and launched cancer products into a much larger market than prenatal screening, while competing with genetics companies like Natera, Myriad Genetics, and Guardant Health rather than only prenatal labs.2 5

The next phase is broadening from a strong prenatal wedge into a multi assay molecular diagnostics company. If BillionToOne keeps proving that its platform can find extremely sparse sequence changes faster and more reliably than standard methods, expansion into confirmation testing, oncology monitoring, and adjacent genetics panels can make the company look less like a single category lab and more like a general purpose precision testing platform.1 2 4 5